A study led by Geisinger Health System engineer Daniel Markle and Cambridge University Chemical Engineering professor Axel Zeitler demonstrated the viability of 3D printing technology in structuring and printing active pharmaceutical ingredient (API) formulations. Read more at 3DPrint.com: https://3dprint.com/164801/accuracy-...l-3d-printing/